ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $37,913,000 | 7.02% |
| Eagle Health Investments LP | 441,466 | $15,005,000 | 4.76% |
| Rappaport Reiches Capital Management, LLC | 133,330 | $4,531,887 | 4.48% |
| Matrix Capital Management Company, LP | 11,572,590 | $393,352,000 | 4.48% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,019,486,000 | 2.80% |
| Aristotle Atlantic Partners, LLC | 727,334 | $24,722,000 | 1.64% |
| DDD Partners, LLC | 316,927 | $10,772,000 | 1.61% |
| Hedeker Wealth, LLC | 117,500 | $3,993,000 | 1.23% |
| Casdin Capital, LLC | 1,440,000 | $48,946,000 | 1.22% |
| BERYLSON CAPITAL PARTNERS, LLC | 61,000 | $2,073,000 | 0.96% |